Private Healthcare in India Needs a Fresh Social Contract

When you start a conversation about India’s health system, the first uncomfortable fact you can’t ignore is that the private sector already handles the lion’s share of care – roughly 60 % of all hospitalisations and about 70 % of outpatient visits. In many cities, two‑thirds of the beds people actually end up in belong to private owners.

That isn’t a criticism; it’s a reality. Corporate hospitals have the equipment, the specialists and the cash to deliver complex surgeries that the public system simply can’t scale. They have also turned India into a hotspot for medical tourism, pulling in more than six lakh foreign patients in 2024 alone – a three‑fold jump from 2020.

What the private world has brought is undeniable: capital, management know‑how and a willingness to set up facilities in Tier 2 and Tier 3 towns that previously had none. But alongside that progress has crept a growing crisis of trust, sparked by stories that sound almost old‑fashioned in their shock value.

Take the recent Maharashtra Food and Drugs Administration surprise – an infusion set that should have cost a little over ten rupees was billed to a patient at 325 rupees, a markup of almost 2,800 %. A decade earlier a similar scandal erupted in Gurugram, where a seven‑year‑old dengue patient’s bill showed a 1,700 % margin on basic consumables. When the headlines repeat themselves after ten years, you start to suspect that it isn’t just a few rogue doctors, but a deeper structural problem.

The market is being reshaped by a flood of speculative capital. Between 2022 and 2024, more than $30 billion changed hands in mergers, acquisitions and private‑equity deals across the health sector, with hospitals swallowing nearly 40 % of that value. That money can build beds, buy MRI machines and train specialists – all things India needs. Yet private equity also expects swift, sizable returns.

Consider the case of Sahyadri Hospitals. In 2022 the Ontario Teachers’ Pension Plan poured about ₹900 crore into the Pune‑based chain, only to sell its stake to Manipal Hospitals three years later for roughly ₹6,000 crore. The price tripled, no doubt pleasing investors, but it also raises the question: what happens when the clock ticking for an exit strategy runs faster than the clock ticking for clinical maturity?

International evidence sounds a cautionary note. A 2023 BMJ review of 55 studies across eight countries linked private‑equity ownership to higher patient costs and, in many cases, mixed or even deteriorating clinical quality. A JAMA analysis of over 4.8 million Medicare stays found a 25 % rise in hospital‑acquired adverse events after private‑equity takeovers, even as procedure volumes fell.

Why does the market fail patients in the first place? Health economics teaches us that typical market mechanisms stumble when the buyer is vulnerable – think of a person lying on an emergency‑room stretcher, unable to shop around, compare prices or even understand the clinical jargon. Add to that the fee‑for‑service model that rewards more tests, longer stays and extra procedures regardless of whether they improve outcomes.

This isn’t a call to shut the doors on private hospitals. They need to stay financially viable; otherwise, investments dry up and innovation stalls. But profitability must be balanced with a fiduciary duty that hospitals owe to patients – a duty that hotels or retail chains simply don’t have.

What we need, then, is a four‑pillar social compact that reshapes the relationship between private providers, regulators and the public.

1. End opaque pricing. Hospitals should post digital, standardised charge schedules and give patients binding, itemised estimates before any planned admission. For high‑value items like implants, the procurement price, the manufacturer’s MRP and the final patient price must all be visible.

2. Tie payments to outcomes, not volume. Fee‑for‑service incentives should be replaced with bundled payments, diagnosis‑related groups or value‑based contracts that reward real improvements in health – fewer infections, lower readmission rates and higher patient‑satisfaction scores.

3. Strengthen public‑private partnership governance. Programs like PM‑JAY can negotiate fair rates, but they must also enforce quality standards, audit billing practices and penalise overcharging. A transparent, auditable framework will curb the temptation to chase quick profits at the expense of care.

4. Create guardrails for private‑equity investment. Disclosure of ultimate beneficial owners, caps on short‑term exit horizons and mandatory reinvestment clauses for a portion of returns can ensure that capital fuels expansion rather than squeezes margins.

Implementing these steps won’t be easy – it will require political will, industry cooperation and vigilant civil‑society oversight. Yet if the private sector truly wants to earn the trust of a billion‑plus people, it has to move beyond the old‑school model of ‘more beds, more revenue’ to one where affordability, accountability and quality are woven into every contract, every bill and every bedside conversation.

In short, India’s health future depends on a new social contract – a pact that lets private hospitals keep innovating while guaranteeing that patients receive honest, affordable and high‑quality care.